Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05922501 · RECRUITING
Trial details
- NCT number
- NCT05922501
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-31
- Primary completion
- 2028-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.